Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Benzo(a)pyrene coated ferric oxide and aluminum oxide particles: uptake, metabolism and DNA binding in hamster pulmonary alveolar macrophages and tracheal epithelial cells in vitro.

Authors
Cheu-J; Talaska-G; Miller-M; Rice-C; Warshawsky-D
Source
Carcinogenesis 1997 Jan; 18(1):167-175
NIOSHTIC No.
00238489
Abstract
The effects of ferric-oxide (1309371) and aluminum-oxide (1344281) particles coated with benzo(a)pyrene (50328) (BaP) on BaP uptake, metabolism, and DNA binding were examined in pulmonary alveolar macrophages (AM) and tracheal epithelial (HTE) cells obtained from Syrian-golden-hamsters. AM cultures were exposed to 0 to 2.0 milligrams (mg) of radiolabeled BaP coated particles for 24 hours. Liquid scintillation spectrometry was used to determine the intracellular uptake of BaP. AM cultures were also incubated with alpha-naphthoflavone (alpha-NF), a cytochrome-P-450 inhibitor, and carbon-monoxide (CO), an epoxide-hydrolase inhibitor. High performance liquid chromatography was used to analyze BaP metabolites. AMs were cocultured with HTE cells for 24 hours. DNA adducts in the HTE cells were examined via the phosphorus-32 postlabeling assay. The uptake of BaP was significantly higher in AMs treated with BaP coated ferric-oxide particles than in AMs treated with either BaP coated aluminum-oxide particles or BaP alone. The BaP metabolites identified included 4,5-dihydrodiol, 7,8- dihydrodiol, 9,10-dihydrodiol, 3,7-hydroxy, 9-hydroxy, 4,5-quinone, and 3,6-quinone. Metabolism was dose dependent, peaking at a BaP coated ferric-oxide dose of 1.5mg and a BaP coated aluminum-oxide dose of 2.0mg. BaP metabolism was significantly greater in AMs exposed to ferric-oxide particles than in AMs exposed to aluminum- oxide particles or BaP alone. BaP metabolism was significantly reduced in cells cotreated with alpha-NF and alpha-NF plus CO. In the presence of ferric-oxide particles, BaP metabolism was significantly higher in AMs than in HTE cells. Two major DNA adducts, 7R,8S,9S-trihydroxy-10R-(N2-deoxyguanosyl-3'-phosphate) 7,8,9,10-tetrahydrobenzo(a)pyrene and 7S,8R,9R-trihydroxy-10S-(N2- deoxyguanosyl-3'-phosphate) 7,8,9,10-tetrahydrobenzo(a)pyrene, were found. DNA binding in HTE cells was greater in the presence of BaP coated ferric-oxide particles than in the presence of either BaP coated aluminum-oxide particles or BaP alone. Treatment with both inhibitors significantly reduced the relative adduct labeling in the HTE cells. The authors conclude that ferric-oxide can enhance the uptake, metabolism, and DNA binding capabilities of BaP.
Keywords
NIOSH-Publication; NIOSH-Grant; Pulmonary-system-disorders; Grants-other; Alveolar-cells; DNA-adducts; Cellular-uptake; Cell-metabolism; Aluminum-oxides; Iron-oxides; Dose-response; Exposure-levels
Contact
Environmental Health University of Cincinnati 3223 Eden Avenue Cincinnati, OH 45267-0056
CODEN
CRNGDP
CAS No.
1309-37-1; 1344-28-1; 50-32-8
Publication Date
19970101
Document Type
Journal Article
Funding Amount
23930
Funding Type
Grant
Fiscal Year
1997
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-R03-OH-02972
Issue of Publication
1
ISSN
0143-3334
Priority Area
Pulmonary-system-disorders; Other Occupational Concerns; Grants-other
Source Name
Carcinogenesis
State
OH
Performing Organization
University of Cincinnati, Cincinnati, Ohio
TOP